Akero Therapeutics Inc

NASDAQ:AKRO   3:59:56 PM EDT
21.08
+1.03 (+5.14%)
Earnings Announcements

Akero Therapeutics Reports Third Quarter 2021 Financial Results

Published: 11/12/2021 12:47 GMT
Akero Therapeutics Inc (AKRO) - Akero Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update.
Believes Cash, Cash Equivalents and Marketable Securities Will Be Sufficient to Fund Its Current Operating Plan Into Q3 2023.
Qtrly Net Loss per Share $0.70.
Q3 Earnings per Share View $-0.91 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.82

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.76

More details on our Analysts Page.